why choose us

Clinical Trials Search

Showing 14,200 of 132,963 result(s)
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Status: Completed

Condition: Advanced or Metastatic Solid Tumors

Interventions: Oral medication taken daily

Date: 2023-03-17

Effect of Radial Shockwave on Calf Muscle Spasticity in Patients With Cerebral Palsy

Status: Completed

Condition: Cerebral Palsy

Interventions: One session per week of rSWT will be applied using the BMI-1120 SHOCK MED device (BIO-MED-INC- ITALY).
The following parameters will be used: Sho

Date: 2023-03-17

Blood Donation Could Improve Insulin Sensitivity

Status: Completed

Condition: Ferritin

Interventions: Effects of a standard whole blood donation on iron stores and insulin sensitivity.

Date: 2023-03-17

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Status: Completed

Condition: SCN2A Encephalopathy

Interventions: Once daily oral or G-tube treatment.

Date: 2023-03-17

A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors

Status: Completed

Condition: Advanced Solid Tumor

Interventions: Part 1: IV infusion of LB101 Q2W (28-day cycle) and Part 2: IV infusion of LB101

Date: 2023-03-17

Dietary Optimization of Microbiome Recovery Following Fecal Microbiota Transplantation

Status: Completed

Condition: Recurrent Clostridium Difficile Infection

Interventions: Participants will be asked to adhere to their randomized MEND diet for 4 weeks and FMT.
The FMT being offered is part of standard clinical care,

Date: 2023-03-17

ECMO Hemostatic Transfusions in Children

Status: Completed

Condition: Extracorporeal Membrane Oxygenation Complication

Interventions: Participants will be transfused according to the assigned threshold for each group, with a transfusion dose of 10 mL;kg, up to one adult unit.

Date: 2023-03-17

Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms

Status: COMPLETED

Condition: Hematopoietic and Lymphoid System Neoplasm

Interventions: Ancillary studies

Date: 2023-03-17

Proof of Concept Study of Latanoprost;Minoxidil (ANR-001.1) Topical Formulation

Status: Completed

Condition: Hypotrichosis

Interventions: Latanoprost and Minoxidil formulation for the treatment of hypotrichosis of the eyebrows.

Date: 2023-03-17